How bio-tech profiteers comes up with their euphemistical chem-names is a reflection of the garbage they profess. And, if you don't abide by their liking, watch out, as they have a serious propaganda mission at hand, as this New York Times article brings to light in a work of chemical artistry.

	Cancer Experts Threatened After Opposing Drug 4 June 2007 - nytimes.com CHICAGO, June 3 — Two prominent prostate cancer experts have been threatened for opposing approval of a controversial new drug and are being protected by bodyguards as they attend the nation’s largest cancer conference here.
	Comment: It is important for those in power to keep you in fear because when you begin to fight back, and loose their illusion of power, things begin to go right, and this is feared even more by those who would prefer you spend your entire life in fear of them. The experts, Dr. Howard Scher of Memorial Sloan-Kettering Cancer Center and Dr. Maha Hussain of the University of Michigan, received e-mail and other threats, according to spokeswomen for Sloan-Kettering and for the cancer conference. It is not known who sent the threats. However, it is clear that the doctors’ public stance against the drug, Provenge, has inflamed the passions of some men with prostate cancer and patient advocates, who say the drug would offer hope to desperate patients with few or no alternatives.
	Comment: Who sez? Where is the documentation of that statement? Is not the advocate the front group for the bias? Of course it is! We do not see patients holding picket signs demanding this chem product. Influence has gotten to the doctors who have shared information about new drugs with their patients before they are approved. Many investors also have made big bets on the stock of the drug’s developer, Dendreon, a Seattle biotechnology company, whose stock has fluctuated wildly along with the prospects for the drug. Some investors stood to profit if the drug was approved, and others if it was rejected.
	Comment: Isn't that wonderful? That is like lining people up to shoot them by throwing big rocks until you hit one and they are murdered. If you kill a few, you profit. If you miss a few, you profit. The Food and Drug Administration said in May that it would not approve Provenge without more evidence that it was safe and effective.
	Comment: Very clever indeed. First, give the illusion that you care when you do not, and then slowly stick the needle of death inward. Patients with incurable diseases often advocate for approval of new drugs even if the data supporting them are not perfect. But threats to people with opposing views to take such advocacy to a new level. That could discourage rational discussion of drugs or deter experts from serving on government advisory committees, where Drs. Scher and Hussain first publicly voiced their opinions.
	Comment: IT WILL NEVER DISCOURAGE IT, YOU WISH. More fear is on the plate. It is true that more government is discouraged. “Intimidation or harassment is going to make qualified people think twice about serving in national positions,” Dr. Hussain said in a brief conversation here at the annual meeting of the American Society of Clinical Oncology. She said she would continue for now to serve on the administration’s advisory panels, but declined to comment further, saying she did not want to inflame the situation.
	Comment: Again, you wish. Notice she didn't quit. Dr. Scher also was reluctant to comment, saying “This is a situation I’ve never been in before.” But he seemed distressed that other doctors were not rallying to his support. “There’s no one else standing up and saying this is ridiculous,” he said.
	Comment: For the mere reason you and your war mongering profiteers are threatening him and everyone does not want to be threatened, nor do they deserve to be threatened for standing up for a fair shake. When he gave a talk at the conference on Sunday, Dr. Scher was accompanied by three men wearing suits and earphones, but not conference name badges, which attendees must wear.
	Comment: What's the point here? Are you trying to say that his guards were inappropriate to your perversions? Shessh! Talk about double speak! A spokeswoman for the oncology association said it had been working with the two doctors and was increasing security at the conference. Christine Hickey, a spokeswoman for Sloan-Kettering, said Dr. Scher had received e-mail messages and phone calls, including one e-mail entitled “your murder.” A copy of his biographical page on the Sloan-Kettering website was vandalized.
	Comment: See end of this article. Provenge has become the latest focal point of a long-running and sometimes bitter debate about the degree of evidence needed for approval of drugs for life-threatening diseases. An F.D.A. advisory panel endorsed the effectiveness of the drug by a 13-4 vote in March. The panel voted 17-0 that the drug was generally safe, although there were signs it could increase the risk of strokes.
	Comment: It is generally safe to walk across a highway as long as there are no cars or trucks on it. If this is advise, we need serious help. Provenge was found to extend lives in two small clinical trials, though the results were somewhat weak by various statistical standards.
	Comment: SOMEWHAT WEAK? VARIOUS STATISTICS? Wouldn't it be easier to just throw rocks? But both Dr. Scher and Dr. Hussain, who, unlike most of the panel members, actually treat patients with prostate cancer, voted in the minority. They argued that the evidence fell short of proving that the drug worked, and that they did not want to give patients false hope. Each doctor later wrote a letter to the F.D.A. reiterating their arguments. About 15 prostate cancer survivors and advocates held a demonstration here on Saturday to urge the agency to approve Provenge. A larger rally is planned for Washington today.
	Comment: It would appropriate to know who has been paid for their services, wouldn't you agree? Dr. Charles Bennett, who organized the Saturday protest, said it was peaceful.
	Comment: Oh, now we possibly know of one. “I absolutely don’t condone and would abhor any threatening behavior,” said Dr. Bennett, a Wisconsin physician whose grandfather and an uncle died from prostate cancer. “That is way over the line.”
	Comment: VERY, VERY CLEVER. Killing many birds with many stones, are we? First, we get the guys who are on our side to debunk the enemy into submission while at the same time putting fear into the minds of the reader about dying from cancer. You are a piece of work. But he added, “There are a lot of guys with prostate cancer who are very passionate” about Provenge.
	Comment: VERY PASSIONATE? I would say, euphemistically intentional implicated propaganda.

For the record:

Federal environmental officials have fined Memorial Sloan-Kettering Cancer Center $214,420 for improperly disposing of chemotherapy waste and other hazardous materials. The Environmental Protection Agency discovered the violations during a random inspection of the hospital last March. Chemicals used for chemotherapy, along with dental fillings, which contain mercury, were kept in standard red biohazard containers, but regulations require more specific identification of the content, Elizabeth Zimmerman, an agency spokeswoman, said yesterday. Christine Hickey, a hospital spokeswoman, said the chemotherapy chemicals were originally handled and labeled as regulated medical waste and not as hazardous chemical waste, as regulations require. Since the violations were noted, the hospital has been using the more specific terms, she said. Anthony DePalma (NYT) posted January 28, 2004

Comments: In the first article, you will notice that Christine Hickey is the spokeswoman who gives out the gross details of an email to the media, but at the same time, can change the terms of disclosure in order to hide violations of health and safety. Is this the kind of person that should be speaking for the two doctors in such a way? Don't you find that odd? Of course, the doctors are forced to walk the line, or they may lose their jobs, and they have the right to refuse the use of such chemical applications even to patients who demand it if they feel it may endanger people.

Step Outside the Med Box:

Patients who are uninformed, or are uneducated, run the greatest risks of all in prevention of diseases. If doctors are influenced by drug pushers, then the integrity of the patient is breeched, only for the reason of respect to those who do not have the proper knowledge to both make decisions, and prevent poor health. Investors are obviously getting in the way of this bond, and we must also remember, the implementation of influence carries with it a host of much deeper problems associated with a form of genocide against poorer people, as drug costs are, to put it mildly, pathetically influenced by profiteers.

Patients should be directed to study alternative medicine over all new drugs. This is the best bond of trust, for natural and homeopathic remedies have lasted for centuries, and do not carry with them the chemical dangers.

References:

Death By Medicine
Pfizer sued for $8 Billion over deadly drug test
Four chemist at former drug maker admit falsifying data
Big Pharma Merck set up offshore accounts to avoid U.S. taxes; settles with IRS for $2.3 billion
Drugs giant faces criminal charges over clinical trial